Henry Schein Reaches New 52-Week High (HSIC)

NEW YORK ( TheStreet) -- Henry Schein (Nasdaq: HSIC) hit a new 52-week high Monday as it is currently trading at $78.56, above its previous 52-week high of $78.16 with 62,382 shares traded as of 9:45 a.m. ET. Average volume has been 479,700 shares over the past 30 days.

Henry Schein has a market cap of $6.8 billion and is part of the services sector and wholesale industry. Shares are up 17.4% year to date as of the close of trading on Friday.

Henry Schein, Inc. distributes healthcare products and services primarily to office-based healthcare practitioners. It operates in two segments, Healthcare Distribution and Technology. The company has a P/E ratio of 18.7, equal to the average wholesale industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Henry Schein as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Henry Schein Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

Henry Schein: Cramer's Top Takeaways

Stocks Are Fighting Back: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)

Analysts' Actions -- Lululemon, L Brands, Masco, Under Armour and More

End of Health-Care Bill Could Be a Win for Markets: Cramer's 'Mad Money' Recap (Friday 3/24/17)

Walmart, Nike, Henry Schein Set to Shine